Journal List > J Korean Ophthalmol Soc > v.55(12) > 1009872

Lee, Shin, and Lee: Clinical Characteristics and Course in Divergence Paralysis

Abstract

Purpose

To improve the understanding of divergence paralysis by identifying its clinical characteristics.

Methods

We performed a retrospective chart review analysis of patients diagnosed with divergence paralysis that were followed up for at least 6 months. Clinical features, including disease onset, course, neurological examinations, and imaging studies were evaluated.

Results

Fifteen patients were included in the present study and the average age was 55.6 years. Thirteen patients had an acute onset and 2 had an insidious onset. The initial distance deviation ranged from 4 to 14 prism diopters (PD) of esotropia (mean, 8 PD esotropia) and near deviation ranged from 6 PD exophoria to 10 PD esophoria (mean, 1.2 PD esophoria). None of the patients developed additional neurological disorders associated with divergence paralysis during the follow-up period. Eleven of 13 patients with primary divergence paralysis continued to depend on the prism glasses with the same diopters. In the 2 patients with secondary divergence paralysis, distant diplopia disappeared as the underlying disease improved.

Conclusions

In our study, the majority of divergence paralysis was not associated with neurological diseases and the patients had an acute onset. Primary divergence paralysis lasted for an extended period. However, secondary divergence paralysis was resolved quickly as the underlying disease improved.

References

1. Bielschowsky A. Lectures on motor anomalies of the eyes: III. Paralysis of conjugate movements of the eyes. Arch Ophthalmol. 1935; 13:580–5.
2. von Noorden GK, Campos EC. Binocular vision and ocular motility: theory and management of strabismus. 6th ed.St. Louis: Mosby;2002. p. 505–6.
3. Jacobson DM. Divergence insufficiency revisited: natural history of idiopathic cases and neurologic associations. Arch Ophthalmol. 2000; 118:1237–41.
4. Wiggins RE Jr, Baumgartner S. Diagnosis and management of divergence weakness in adults. Ophthalmology. 1999; 106:1353–6.
crossref
5. Sargent JC. Nuclear and infranuclear ocular motility disorders. Miller NR, Newman NJ, editors. Walsh and Hoyt's Clinical Neuro-Ophthalmology. 6th ed.Baltimore: Williams & Wilkins;2005. 1:chap. 20.
6. Krohel GB, Tobin DR, Hartnett ME, Barrows NA. Divergence paralysis. Am J Ophthalmol. 1982; 94:506–10.
crossref
7. Thomas AH. Divergence insufficiency. J AAPOS. 2000; 4:359–61.
crossref
8. Lim L, Rosenbaum AL, Demer JL. Saccadic velocity analysis in patients with divergence paralysis. J Pediatr Ophthalmol Strabismus. 1995; 32:76–81.
crossref
9. Bruce GM. Ocular divergence: Its physiology and pathology. Arch Ophthalmol. 1935; 13:639–60.
crossref
10. Cunningham RD. Divergence paralysis. Am J Ophthalmol. 1972; 74:630–5.
crossref
11. Bakker SL, Gan IM. Temporary divergence paralysis in viral meningitis. J Neuroophthalmol. 2008; 28:111–3.
crossref
12. Arai M, Fujii S. Divergence paralysis associated with the ingestion of diazepam. J Neurol. 1990; 237:45–6.
crossref
13. Kirkham TH, Bird AC, Sanders MD. Divergence paralysis with raised intracranial pressure. An electro-oculographic study. Br J Ophthalmol. 1972; 56:776–82.
crossref
14. CHAMLIN M, DAVIDOFF LM. Divergence paralysis with increased intracranial pressure. J Neurosurg. 1950; 7:539–43.
crossref
15. Pinchoff BS, Slavin ML, Rosenstein D, Hyman R. Divergence paralysis as the initial sign in the Miller Fisher syndrome. Am J Ophthalmol. 1986; 101:741–2.
crossref
16. Rosenbaum AL, Kushner BJ, Kirschen D. Vertical rectus muscle transposition and botulinum toxin (Oculinum) to medial rectus for abducens palsy. Arch Ophthalmol. 1989; 107:820–3.
crossref
17. Park UC, Kim SJ, Hwang JM, Yu YS. Clinical features and natural history of acquired third, fourth, and sixth cranial nerve palsy. Eye (Lond). 2008; 22:691–6.
crossref
18. King AJ, Stacey E, Stephenson G, Trimble RB. Spontaneous recovery rates for unilateral sixth nerve palsies. Eye (Lond). 1995; 9(Pt 4):476–8.
crossref

Table 1.
Clinical characteristics and course in divergence paralysis patients
No. Age (years) Sex Onset Interval from onset to first visit (months) Medical history MRI Angle of deviation
Management (prism therapy) Duration of F/U (months) Natural course (last F/U)
Distant (PD) Near (PD)
1 81 F Acute 2 HTN 4 ET 0 B) 3 PD BO 9 No change
2 37 M Acute 0.17 YES 10 ET 2 E B) 5 PD BO 17 No change
3 76 M Acute 7 DM 8 ET 2 E B) 3 PD BO 24 No change
4 55 M Acute 6 YES 6 ET 4 X L) 4 PD BO 35 No change
5 64 M Acute 0.5 8 ET 3 RHT 10 X L) 6 PD BO 45 No change
6 52 M Insidious 84 8 ET 2 E B) 4 PD BO 7 No change
7 70 M Acute 24 HTN/MI 8 ET 0 B) 3 PD BO 6 No change
8 55 M Insidious 12 DM YES 6 E 0 B) 3 PD BO 13 No change
9 56 M Acute 6 YES 4 E 6 X R) 4 PD BO 14 No change
10 35 F Acute 0.23 Hypertensive retinopathy 10 ET 4 ET B) 5 PD BO 6 Spontaneous recovery
11 68 F Acute 6 DM/HTN YES 14 ET 6 E B) 6 PD BO 8 No change
12 22 M Acute 0.07 YES 10 ET 0 B) 5 PD BO 6 Spontaneous recovery
13 67 F Acute 0.1 HTN YES 14 ET 0 B) 7 PD BO 6 Spontaneous recovery
14 28 M Acute 0.25 Tb meningitis YES 6 ET 2 E B) 3 PD BO 6 Spontaneous recovery
15 68 M Acute 2 YES 4 ET 0 B) 3 PD BO 9 No change

PD = prism diopter; F/U = follow up; HTN = hypertension; DM = diabetes mellitus; MI = myocardial infarction; Tb = tuberculosis; ET = esotropia; RHT = right hypertropia; E = esophoria; X = exophoria; B = both; L = left; R = right; BO = base out.

TOOLS
Similar articles